Phoslo
Indicated to target serum phosphate levels, utilized to alleviate hyperphosphataemia in patients with chronic kidney disease.
Strengths: 667mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Phosphate Binder
- Pharmacological class
Calcium Salt
- Contraindications
hypercalcaemia
- Precautions and warnings
assess serum calcium levels periodically; take with meals
- Minor side effects
nausea; constipation
- Moderate side effects
hypercalcaemia; vomiting
- Serious side effects
soft tissue calcification — requires immediate medical attention
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Fresenius Kabi
- Onset Time
immediate
- Duration
with each meal
- Storage instructions
Store at room temperature.
- Drug interactions
tetracycline antibiotics; quinolone antibiotics
- Age restrictions
Consult medical advice for paediatric dosing.
- Pregnancy and breastfeeding
Pregnancy: Use with caution. Breastfeeding: Consult a physician.
Patient summary
Indicated to target serum phosphate levels, utilized to alleviate hyperphosphataemia in patients with chronic kidney disease.
Mechanism of action
Calcium acetate works by binding to dietary phosphate in the gastrointestinal tract. This forms insoluble calcium phosphate, which is then excreted in the faeces, preventing the absorption of phosphate into the bloodstream.
Phoslo
Indicated to target serum phosphate levels, utilized to alleviate hyperphosphataemia in patients with chronic kidney disease.
Editorial Notes
- Active ingredient(s): Calcium Acetate
- Listed indication(s): Hyperphosphataemia
Available option
- 360 tablets - 667 mg629-667-mg-3807